Evaluation and Characteristics of a New Direct Compression Performance Excipient - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Evaluation and Characteristics of a New Direct Compression Performance Excipient
The authors investigated the tableting properties of PanExcea MHC300G, a high-performance excipient.


Pharmaceutical Technology
Volume 35, Issue 3

References

1. D. McCormik, Pharm. Technol. 5, (4) 52–62 (2005) .

2. N.A. Armstrong, Encyclopedia of Pharmaceutical Technology, Informa Healthcare USA, Inc. (New York, Third Edition, 2006).

3. H.G. Kristensen and T. Schaefer, Drug Dev. and Ind. Pharm. 13, 803–872 (1987).

4. A.J. Hlinak, et al., J. of Pharm. Innov. 1, 12–17 (2006).

5. M. Jivraj, L.G. Martini, C.M. Thomson, Pharm. Sci. and Technol. Today, 3, 58–63 (2000).

6. R.J. Roberts, R.C. Rowe, Int. J. of Pharm. 36, 205–209 (1987).

7. K. van der Voort Maarschalk, G.K. Bolhuis, Pharm. Technol. 23, 34–46 (1999).

8. K. van der Voort Maarschalk et al., Int. J. of Pharm. 151, 27–34 (1997).

9. G.K. Bolhuis, N.A. Armstrong, Pharm. Dev. and Technol. 11, 111–124 (2006).

10. G. Bubb, Tablets and Capsules, 7, (2007).

11. IPEC–Americas, Frequently Asked Questions web page, http://ipecamericas.org/about/faqs/, accessed Feb. 16, 2011.

12. N. Deorkar, Tablets and Capsules, 8, 22–26 (2008).

13. L. Mīinea, J. Farina, M. Kallam, N. Deorkar, Pharm. Processing, Feb. 2009, http://www.pharmpro.com/Articles/2009/03/A-New-World-of-Excipients-for-Oral-Solid-Dosage-Formulation/, accessed Feb. 16, 2011.

14. S.K. Nachaegari, A.K. Bansal, Pharm. Technol. 28 (1) 52–64 (2004).

15. M.C. Gohel, P.D. Jogani, J. of Pharm. and Pharm. Sci. 8, 76–93 (2005).

16. C. Moreton, "Functionality and Performance of Excipients in a Quality-by-Design World: Parts 1–6," a series of papers published in each issue of vol. 12 of American Pharmaceutical Review (2009).

17. N. Deorkar, J. Farina, L. Mīinea, S. Randive, "Directly Compressible High Functionality Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof" PCT/US2008/011555 (Oct. 2008).

18. Mallinckrodt Baker, product profile for PanExcea MHC300G, http://www.mallbaker.com/Literature/Documents/PanExcea%20IR%20Product%20Profile%20Lit7001.pdf, accessed Feb. 16, 2011.

19. L. Mīinea, R. Mehta, J. Farina, N. Deorkar, "Granular Excipients Based on Microcrystalline Cellulose: DOE study of a lab-based scale high shear granulation process," poster presentation at "Excipient Fest Americas", (Puerto Rico, April 2008).

20. USP 34–NF 29 General Chapter <1174> "Powder Flow."

21. Carr, R. L. Chem. Eng. 72,163–168, 1965.

22. Hosokawa Micron, product profile for Hosokawa Micron Powder Characteristics Tester PT-S, http://www.hosokawa.co.uk/powdtest.php, accessed Feb. 16, 2011.

23. S.I.F. Badawy, D.B. Gray, M.A. Hussain, Pharm. Res. 23, 634–640 (2006).

24. T. Suzuki et al., J. of Pharm. and Pharmacol. 53, 609–616 (2001).

25. C.K. Tye, C. Sun, G.E. Amidon, J. of Pharm. Sci. 94, 465–472 (2005).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
28%
Attracting a skilled workforce
26%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
33%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here